Net Cash Provided by (Used in) Operating Activities |
-4.42M |
USD |
+2.62% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
125M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
25.3M |
shares |
+20.6% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-4.43M |
USD |
+2.34% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
16.9M |
USD |
-43.2% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
174M |
USD |
+2.44% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
174M |
USD |
+2.44% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-123M |
USD |
-2797% |
Q2 2024 |
Q2 2024 |
Property, Plant and Equipment, Gross |
84K |
USD |
+20% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
74M |
USD |
+0.87% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
4K |
USD |
+33.3% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
1.41M |
USD |
+14.5% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |